91Ó°ÊÓ

When performing hypothesis tests in statistics, a Type I error occurs when a true null hypothesis is incorrectly rejected. It's like a false alarm; the evidence suggests there is an effect or a difference when in actuality, there isn't one. Imagine you're a juror in a trial and the accused is actually innocent, but based on the evidence presented, the jury concludes they are guilty. That's a Type I error in the court of law.

In the context of the pharmaceutical company example, if they choose a larger significance level such as \(\alpha=0.10\), they increase their chances of a Type I error, meaning they might conclude that their new drug is better than the existing one when it may not be. The consequence is potentially marketing a drug that's not genuinely superior, affecting both their reputation and consumer health.

It's essential to control the risks of Type I errors, especially in fields like medicine, where the stakes are high. Accepting such errors might lead to adopting ineffective treatments or abandoning good ones. Hence, researchers must be very careful in setting an appropriate significance level to minimize Type I errors.

The null hypothesis is a general statement or default position that there is no relationship between two measured phenomena or no association among groups. It is usually symbolized as \(H_0\) and serves as a starting point for any statistical test of significance.

In the exercise, the null hypothesis would be that the new drug is not better than the existing drug. The goal in hypothesis testing is to determine whether we have enough evidence to reject the null hypothesis.

Establishing a null hypothesis provides a basis for measuring how unusual our data would be if this hypothesis were true. As such, it's a critical component in the scientific method of investigation, enabling researchers to use statistical methods to decide whether to support or refute it. The selection of the significance level plays directly into this, as it sets the threshold for how much evidence is necessary to reject the null hypothesis.

The term statistical significance indicates whether the results of a study or an experiment are likely to be due to chance. When findings are statistically significant, it means that the observed differences or correlations are probably not due to random variation but rather an actual effect or relationship.

In the pharmaceutical scenario, statistical significance would help to determine if the new drug genuinely offers a therapeutic advantage over the existing one. This judgement is based on the chosen significance level (\(\alpha\)), which defines the probability threshold for when the null hypothesis can be rejected.

A smaller \(\alpha\), such as 0.01, indicates a stricter criterion for claiming significance and, consequently, a more robust conclusion (with less room for a Type I error). Consumers would find this reassuring, as there's a lower chance that the claimed benefits of the new drug are due to random chance. The company might prefer a higher \(\alpha\) to claim success and market the drug, though this brings a greater risk of concluding effectiveness where there might be none.